Literature DB >> 15688014

Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.

Abdelkader Essafi1, Silvia Fernández de Mattos, Yasmin A M Hassen, Inês Soeiro, Ghulam J Mufti, N Shaun B Thomas, René H Medema, Eric W-F Lam.   

Abstract

In this study, we have used the human BV173 and the mouse BaF3/Bcr-Abl-expressing cell lines as model systems to investigate the molecular mechanisms whereby STI571 and FoxO3a regulate Bim expression and apoptosis. FoxO3a lies downstream of Bcr-Abl signalling and is constitutively phosphorylated in the Bcr-Abl-positive BV173 and BaF3/Bcr-Abl cells. Inhibition of Bcr-Abl kinase by STI571 results in FoxO3a activation, induction of Bim expression and apoptosis. Using reporter gene assays, we demonstrate that STI571 and FoxO3a activate Bim transcription through a FoxO-binding site (FHRE) located within the promoter. This was verified by DNA pull-down and chromatin immunoprecipitation analyses. We find that conditional activation of FoxO3a leads to induction of Bim expression and apoptosis. Conversely, silencing of FoxO3a in Bcr-Abl-expressing cells abolishes STI571-mediated Bim induction and apoptosis. Together, the results presented clearly confirm FoxO3a as a key regulator of apoptosis induced by STI571, and show that Bim is a direct transcriptional target of FoxO3a that mediates the STI571-induced apoptosis. Thus, STI571 induces an accumulation of FoxO3a activity which in turn binds directly to an FHRE in the promoter to activate Bim expression and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688014     DOI: 10.1038/sj.onc.1208421

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  128 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

2.  Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.

Authors:  Xiaoxia Zhong; Erhu Zhao; Chunling Tang; Weibo Zhang; Juan Tan; Zhen Dong; Han-Fei Ding; Hongjuan Cui
Journal:  Tumour Biol       Date:  2015-12-19

Review 3.  FOXO3: A Major Gene for Human Longevity--A Mini-Review.

Authors:  Brian J Morris; Donald Craig Willcox; Timothy A Donlon; Bradley J Willcox
Journal:  Gerontology       Date:  2015-03-28       Impact factor: 5.140

4.  Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A.

Authors:  Angharad M Shore; Paul C White; Rosaline C-Y Hui; Abdelkader Essafi; Eric W-F Lam; Martin Rowe; Paul Brennan
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

Authors:  Shinji Kume; Takashi Uzu; Kihachiro Horiike; Masami Chin-Kanasaki; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

6.  Imatinib spells BAD news for Bcr/abl-positive leukemias.

Authors:  Scott H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

7.  Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence.

Authors:  Sabina Benko; Judy A Fantes; Jeanne Amiel; Dirk-Jan Kleinjan; Sophie Thomas; Jacqueline Ramsay; Negar Jamshidi; Abdelkader Essafi; Simon Heaney; Christopher T Gordon; David McBride; Christelle Golzio; Malcolm Fisher; Paul Perry; Véronique Abadie; Carmen Ayuso; Muriel Holder-Espinasse; Nicky Kilpatrick; Melissa M Lees; Arnaud Picard; I Karen Temple; Paul Thomas; Marie-Paule Vazquez; Michel Vekemans; Hugues Roest Crollius; Nicholas D Hastie; Arnold Munnich; Heather C Etchevers; Anna Pelet; Peter G Farlie; David R Fitzpatrick; Stanislas Lyonnet
Journal:  Nat Genet       Date:  2009-02-22       Impact factor: 38.330

8.  NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy.

Authors:  Chia-Ling Wu; Evangeline W Cornwell; Robert W Jackman; Susan C Kandarian
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-19       Impact factor: 4.249

Review 9.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16

10.  FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells.

Authors:  Silvia Fernández de Mattos; Priam Villalonga; Jon Clardy; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.